search
Back to results

Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash

Primary Purpose

Diaper Rash

Status
Completed
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Liniderm
Wipes
Water
Sponsored by
Laboratoires Gilbert
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diaper Rash focused on measuring Infant diaper rash, Baby wipes, Oleocalcareous liniment

Eligibility Criteria

3 Months - 36 Months (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged 3 - 36 months, in good health, born at term or up to 1 month before term,
  • A skin phototype I- III according to Fitzpatrick scale,
  • Wearing diapers daily with at least 2 changes per day and a night port,
  • For whom parents have given their written informed consent regarding its participation in this clinical investigation.

Exclusion Criteria:

  • Wearing washable or pull-on diapers,
  • Presenting a diaper rash (in progress),
  • Presenting a cutaneous pathology known,
  • Treated actually by phototherapy,
  • Presenting a cow's milk protein allergy,
  • Under medical treatment which may interfere with studied products and/ or skin in the 4-weeks prior to enrolment.

Sites / Locations

  • Dermscan

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Liniderm

Wipes

Water

Arm Description

Oleocalcareous liniment Liniderm: The product will be applied on the diaper area by parents/ caregivers at each diaper change.

Free-fragrance baby wipes The product will be used on the diaper area by parents/ caregivers at each diaper change.

Water and cotton pads The product will be used on the diaper area by parents/ caregivers at each diaper change.

Outcomes

Primary Outcome Measures

Number of infants who had at least one episode of diaper rash
Every day, in a daily log, parents/ caregivers will report the presence or not of a diaper rash. At the end of the follow-up, the investigator must identify infant who have had at least one episode of diaper rash.

Secondary Outcome Measures

Severity of diaper rash episodes: rating
Every day, parents/ caregivers will report the rating of erythema if applicable using an illustrated scale ( 4 points scale). The rating scale is: 0 (Normal skin), 1 (Mild erythema/ pink skin), 2 (Severe erythema/ red skin) and 3 (Erythema with skin erosion).
Severity of diaper rash episodes: extent
Every day, parents/ caregivers will report the extent of erythema if applicable using an illustrated scale ( 4 points scale). The extent scale is: 0 (Healthy skin), 1 (On the folds/ small spread), 2 (On the convexity/ moderate spread) and 3 (Wide spread).
Safety of the cleaning method
Every day, parents will report intolerance/ discomfort felt. Also, at each visit, the investigator will carry out a clinical examination of the diaper area; the investigator will assess the tolerance using a 4-points Likert scale. The 4-points Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
Skin evaluation on the genital area
Assessment of the skin integrity using a numeric scale (6 points) by the paediatrician at each visit. The numeric scale is: 0 (No rash), 1 (Mild irritation or rash), 2 (Moderate irritation or rash), 3 (Considerable irritation or rash), 4 (Extreme irritation or rash) and 5 (Extreme erythema involving entire area, oozing papules, pustules erosion). Skin colour measurements using a Chroma Meter.
Paediatrician satisfaction
The paediatrician's satisfaction (regarding performance) will be assessed for each infant using a 4-point Likert scale. The 4-point Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
Well-being
The well-being of infant will be assessed by parents at each visit. Questions will be about crying, agitation, tension and scratching (Yes/ No).
Parents satisfaction
The parents' satisfaction (regarding performance and safety) will be assessed using a 4-point Likert scale. The 4-point Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)

Full Information

First Posted
July 16, 2018
Last Updated
April 2, 2019
Sponsor
Laboratoires Gilbert
Collaborators
Slb Pharma
search

1. Study Identification

Unique Protocol Identification Number
NCT03640897
Brief Title
Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash
Official Title
Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash: a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
August 2, 2018 (Actual)
Primary Completion Date
March 18, 2019 (Actual)
Study Completion Date
March 18, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Laboratoires Gilbert
Collaborators
Slb Pharma

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Result of immaturity of the skin and factors promoting maceration and mechanical interactions, Irritant diaper dermatitis (IDD) can manifest as early as the third week of life. IDD is a form of contact dermatitis and is the most common inflammatory dermatitis of the diaper area infants. This dermatitis is very common amongst first year of life. The IDD is characterized by erythema on the convex surfaces with the skin folds spared (W-shaped erythema) and it can cause considerable pain and stress for infants and can be troublesome for their caregivers. The development of IDD is multifactorial. The critical step in the development of IDD is the occlusion of the skin under the diaper. The skin in the diaper area is predisposed to irritation by the presence of urine, stool, friction on the skin and presence of a high skin pH (potential Hydrogen). At the cellular level, there is a gradual disorganization of the lipid layers and later an attack of keratinocytes. Clinically, maceration is followed by an inflammatory reaction. Hence, infrequent diaper changes create overhydration and maceration of the stratum corneum, which makes the skin more sensitive to friction; this may interfere with the protective barrier function, allowing for the exposure of the lower layers to irritants (mechanical, chemical and infectious). The removal of maceration and the reduction of friction are the key to prevention. But it is recommended to respect preventive measures, in order to preserve the normal skin condition over the long term. Special care procedures are required to ensure healthy development and to protect the skin from irritation and inflammation, as well as a sense of well-being. Although use of appropriately formulated cleansers and emollients can help maintain the epidermal skin barrier in the diaper region, good hygiene and adequate protection are necessary to prevent skin barrier breakdown, rash and infection. The prevention of IDD includes frequent diaper changing, parent education and cleaning. LiNiRASH is a monocentric, prospective, randomized, comparator controlled study conducted under paediatric control. 132 infants will be followed in this study for 4 weeks during which their parents will use a specific cleaning method: water and cotton pads or wipes or liniment. The objective of this study is to compare the performance and safety of this 3 cleaning methods on the prevention of infant diaper rash.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diaper Rash
Keywords
Infant diaper rash, Baby wipes, Oleocalcareous liniment

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A monocentric, prospective, randomized, comparator controlled, parallel groups study conducted under paediatric control.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
133 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Liniderm
Arm Type
Experimental
Arm Description
Oleocalcareous liniment Liniderm: The product will be applied on the diaper area by parents/ caregivers at each diaper change.
Arm Title
Wipes
Arm Type
Active Comparator
Arm Description
Free-fragrance baby wipes The product will be used on the diaper area by parents/ caregivers at each diaper change.
Arm Title
Water
Arm Type
Active Comparator
Arm Description
Water and cotton pads The product will be used on the diaper area by parents/ caregivers at each diaper change.
Intervention Type
Device
Intervention Name(s)
Liniderm
Intervention Description
Cleaning of the diaper area with Liniderm at each diaper change during 28 days
Intervention Type
Other
Intervention Name(s)
Wipes
Intervention Description
Cleaning of the diaper area with wipes at each diaper change during 28 days
Intervention Type
Other
Intervention Name(s)
Water
Intervention Description
Cleaning of the diaper area with water and cotton pads at each diaper change during 28 days
Primary Outcome Measure Information:
Title
Number of infants who had at least one episode of diaper rash
Description
Every day, in a daily log, parents/ caregivers will report the presence or not of a diaper rash. At the end of the follow-up, the investigator must identify infant who have had at least one episode of diaper rash.
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Severity of diaper rash episodes: rating
Description
Every day, parents/ caregivers will report the rating of erythema if applicable using an illustrated scale ( 4 points scale). The rating scale is: 0 (Normal skin), 1 (Mild erythema/ pink skin), 2 (Severe erythema/ red skin) and 3 (Erythema with skin erosion).
Time Frame
Continuously for 28 days
Title
Severity of diaper rash episodes: extent
Description
Every day, parents/ caregivers will report the extent of erythema if applicable using an illustrated scale ( 4 points scale). The extent scale is: 0 (Healthy skin), 1 (On the folds/ small spread), 2 (On the convexity/ moderate spread) and 3 (Wide spread).
Time Frame
Continuously for 28 days
Title
Safety of the cleaning method
Description
Every day, parents will report intolerance/ discomfort felt. Also, at each visit, the investigator will carry out a clinical examination of the diaper area; the investigator will assess the tolerance using a 4-points Likert scale. The 4-points Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
Time Frame
Continuously for 28 days
Title
Skin evaluation on the genital area
Description
Assessment of the skin integrity using a numeric scale (6 points) by the paediatrician at each visit. The numeric scale is: 0 (No rash), 1 (Mild irritation or rash), 2 (Moderate irritation or rash), 3 (Considerable irritation or rash), 4 (Extreme irritation or rash) and 5 (Extreme erythema involving entire area, oozing papules, pustules erosion). Skin colour measurements using a Chroma Meter.
Time Frame
0, 14 and 28 days
Title
Paediatrician satisfaction
Description
The paediatrician's satisfaction (regarding performance) will be assessed for each infant using a 4-point Likert scale. The 4-point Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
Time Frame
14 and 28 days
Title
Well-being
Description
The well-being of infant will be assessed by parents at each visit. Questions will be about crying, agitation, tension and scratching (Yes/ No).
Time Frame
0, 14 and 28 days
Title
Parents satisfaction
Description
The parents' satisfaction (regarding performance and safety) will be assessed using a 4-point Likert scale. The 4-point Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
Time Frame
14 and 28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
36 Months
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Aged 3 - 36 months, in good health, born at term or up to 1 month before term, A skin phototype I- III according to Fitzpatrick scale, Wearing diapers daily with at least 2 changes per day and a night port, For whom parents have given their written informed consent regarding its participation in this clinical investigation. Exclusion Criteria: Wearing washable or pull-on diapers, Presenting a diaper rash (in progress), Presenting a cutaneous pathology known, Treated actually by phototherapy, Presenting a cow's milk protein allergy, Under medical treatment which may interfere with studied products and/ or skin in the 4-weeks prior to enrolment.
Facility Information:
Facility Name
Dermscan
City
Gdańsk
Country
Poland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash

We'll reach out to this number within 24 hrs